Stockscreener 앱 받기
24.85
7.50%
1.7778
전일 마감가:
$23.07
열려 있는:
$23.07
하루 거래량:
127.81K
Relative Volume:
0.49
시가총액:
$1.11B
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+19.23%
1개월 성능:
+73.67%
6개월 성능:
+333.57%
1년 성능:
+0.00%
1일 변동 폭
$22.64
$24.88
1주일 범위
$20.18
$24.88
52주 변동 폭
$4.17
$28.99
Septerna Inc Stock (SEPN) Company Profile
명칭
Septerna Inc
전화
650-338-3533
주소
250 EAST GRAND AVENUE, SUITE 65, SOUTH SAN FRANCISCO
SEPN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SEPN
Septerna Inc
|
24.85 | 1.03B | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.30 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
471.66 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
556.06 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
807.20 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
331.64 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Septerna Inc Stock (SEPN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-23 | 개시 | H.C. Wainwright | Buy |
| 2025-02-18 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2024-11-19 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-11-19 | 개시 | JP Morgan | Overweight |
| 2024-11-19 | 개시 | TD Cowen | Buy |
| 2024-11-19 | 개시 | Wells Fargo | Overweight |
모두보기
Septerna Inc 주식(SEPN)의 최신 뉴스
Septerna Inc. stock trend forecast2025 Performance Recap & Advanced Swing Trade Entry Plans - newser.com
Septerna Inc. stock trend outlook and recovery path2025 Investor Takeaways & Weekly Momentum Picks - newser.com
Is Septerna Inc. stock a safe haven assetInflation Watch & High Return Trade Guides - newser.com
Momentum divergence signals in Septerna Inc. chartJuly 2025 Summary & Community Verified Swing Trade Signals - newser.com
Septerna (NASDAQ:SEPN) Shares Gap DownHere's Why - MarketBeat
Will Septerna’s (SEPN) Latest Board Appointment Strengthen Its R&D Edge or Reinforce the Status Quo? - simplywall.st
Using data tools to time your Septerna Inc. exitMarket Performance Report & Real-Time Buy Zone Alerts - newser.com
Septerna Inc Stock Analysis and ForecastEarnings Beat Highlights & Maximize Gains Professionally - earlytimes.in
What drives Septerna Inc stock priceTechnical Breakout Signals & Outperform With Our Smart Trading Calculator - earlytimes.in
Septerna (SEPN): Evaluating Valuation Following Dr. Keith Gottesdiener’s Board Appointment - Yahoo Finance
Strength Seen in Septerna, Inc. (SEPN): Can Its 7.0% Jump Turn into More Strength? - Yahoo Finance
Visual analytics tools that track Septerna Inc. performancePortfolio Growth Summary & Free Risk Controlled Daily Trade Plans - newser.com
Weiss Ratings Reaffirms "Sell (D-)" Rating for Septerna (NASDAQ:SEPN) - MarketBeat
Multi asset correlation models including Septerna Inc.Trade Risk Assessment & Free High Return Stock Watch Alerts - newser.com
Price momentum metrics for Septerna Inc. explainedGold Moves & Short-Term Trading Alerts - newser.com
How Septerna Inc. stock performs in high volatility markets2025 Winners & Losers & Daily Profit Focused Screening - newser.com
Septerna (NASDAQ:SEPN) Shares Up 8.5%Should You Buy? - MarketBeat
Septerna plunges as safety concerns force an end to early-stage trial - MSN
How hedge fund analytics apply to Septerna Inc. stockJuly 2025 Review & Accurate Intraday Trade Tips - newser.com
Real time breakdown of Septerna Inc. stock performanceJuly 2025 Reactions & Consistent Income Trade Recommendations - newser.com
Is Septerna Inc. stock entering bullish territory2025 Winners & Losers & Long-Term Growth Plans - newser.com
Septerna, Inc. (NASDAQ:SEPN) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
We're Not Worried About Septerna's (NASDAQ:SEPN) Cash Burn - Sahm
Are Options Traders Betting on a Big Move in Septerna Stock? - Yahoo Finance
Can Septerna Inc. stock hit analyst price targetsJuly 2025 Highlights & Entry Point Confirmation Signals - newser.com
Using RSI to spot recovery in Septerna Inc.Quarterly Risk Review & Long-Term Capital Growth Strategies - newser.com
Septerna Up 12%, Insider Buyers Are Up 219% - Yahoo Finance
Septerna appoints Keith Gottesdiener to board of directors By Investing.com - Investing.com Nigeria
Septerna Begins Phase 1 Trial for SEP-631 - MSN
Septerna, Inc. Expands Board with New R&D Chair - TipRanks
Septerna appoints Keith Gottesdiener to board of directors - Investing.com India
Former Prime Medicine CEO and 20+ Drug Approval Leader Keith Gottesdiener Joins Septerna's Board - Stock Titan
What analysts say about Septerna Inc stockContrarian Investment Ideas & Low Risk Investment Growth - Early Times
Septerna Inc (SEPN) 재무 분석
Septerna Inc (SEPN)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
Septerna Inc 주식 (SEPN) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Finer Jeffrey | CEO and President |
Apr 02 '25 |
Option Exercise |
2.76 |
50,000 |
138,000 |
821,907 |
| Finer Jeffrey | CEO and President |
Apr 03 '25 |
Option Exercise |
2.76 |
5,000 |
13,800 |
826,907 |
| Ezekowitz Alan | Director |
Mar 07 '25 |
Buy |
6.93 |
13,319 |
92,270 |
117,420 |
| Ezekowitz Alan | Director |
Mar 06 '25 |
Buy |
6.00 |
41,355 |
248,130 |
104,101 |
| Ezekowitz Alan | Director |
Mar 05 '25 |
Buy |
5.82 |
37,835 |
220,260 |
62,746 |
| Ezekowitz Alan | Director |
Mar 04 '25 |
Buy |
6.35 |
7,491 |
47,544 |
24,911 |
| Finer Jeffrey | CEO and President |
Feb 25 '25 |
Buy |
5.68 |
10,000 |
56,765 |
764,907 |
| Finer Jeffrey | CEO and President |
Feb 26 '25 |
Buy |
5.70 |
4,000 |
22,796 |
768,907 |
| Finer Jeffrey | CEO and President |
Feb 27 '25 |
Buy |
5.80 |
3,000 |
17,400 |
771,907 |
| Labrucherie Gil M | Chief Financial Officer |
Feb 25 '25 |
Buy |
5.59 |
6,282 |
35,116 |
36,282 |
1.18%
자본화:
|
볼륨(24시간):